KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Opko Health (OPK) Finished Goods: 2022-2025

Historic Finished Goods for Opko Health (OPK) over the last 3 years, with Sep 2025 value amounting to $42.3 million.

  • Opko Health's Finished Goods rose 23.53% to $42.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $42.3 million, marking a year-over-year increase of 23.53%. This contributed to the annual value of $32.3 million for FY2024, which is 9.20% down from last year.
  • Opko Health's Finished Goods amounted to $42.3 million in Q3 2025, which was up 0.13% from $42.2 million recorded in Q2 2025.
  • In the past 5 years, Opko Health's Finished Goods registered a high of $42.3 million during Q3 2025, and its lowest value of $32.3 million during Q4 2024.
  • Over the past 3 years, Opko Health's median Finished Goods value was $35.3 million (recorded in 2023), while the average stood at $36.6 million.
  • Per our database at Business Quant, Opko Health's Finished Goods fell by 9.20% in 2024 and then rose by 23.53% in 2025.
  • Opko Health's Finished Goods (Quarterly) stood at $37.1 million in 2022, then fell by 4.19% to $35.6 million in 2023, then decreased by 9.20% to $32.3 million in 2024, then rose by 23.53% to $42.3 million in 2025.
  • Its Finished Goods was $42.3 million in Q3 2025, compared to $42.2 million in Q2 2025 and $39.9 million in Q1 2025.